HBO recently adapted the first book in the four-part series for the small screen.
There are an estimated 200 million cases of malaria worldwide each year, and around 600,000 deaths. But the last 15 years represent a success story in the fight against the disease: Increased investment in treatment and prevention have cut the death rate nearly in half. Now, researchers warn that resistance to the primary drug used to treat malaria is spreading. A new study has detected a resistant strain in Myanmar near the Indian border, raising concerns that resistance could soon extend its hold to sub-Saharan Africa, where more than 90 percent of malaria deaths occur. Diane and her guests discuss new concerns about combating malaria worldwide.
- Dr. Lawrence Barat Senior technical advisor to the President's Malaria Initiative at USAID
- Jason Beaubien Global health and development correspondent for NPR
- Dr. Alan Magill Director of the Malaria Program at the Bill & Melinda Gates Foundation
- Laurie Garrett Senior fellow for global health at the Council on Foreign Relations
- Dr. William Moss Professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health; co-director of the Southern Africa International Center of Excellence for Malaria Research
Most Recent Shows
Concerns over user privacy, the continued spread of misinformation and strong-arm tactics to crowd out competitors have users -- and governments -- rethinking their relationships with Facebook.
Why Diane's guest Ben Wittes says no.
In this moment of political discontent, when we talk of deep divides and a growing sense that our democracy has gone off track, historians counsel us to look to our…